Vir Biotechnology, Inc. · NASDAQ:VIR
De Backer Marianne reported 1 trade in Vir Biotechnology, Inc. shares (Form 4)
Traded Apr 29, 2026 · Filed Apr 30, 2026
On Apr 29, 2026, De Backer Marianne (Director, President and CEO) reported 1 trade in Vir Biotechnology, Inc. shares, leaving 714,613 shares. Filed Apr 30, 2026 (Form 4).
- Shares
- 233,532 shares
- Holding after
- 714,613 shares
- Trading plan
- No
- Role
- Director, President and CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 29, 2026 | Common Stock | Other | 233,532 | 714,613 | Direct |
Source
Related
- Vir Biotechnology, Inc.
- De Backer Marianne
- Vir Biotechnology, Inc. shareholders
- Form 4 · De Backer Marianne · Apr 7, 2026
- Form 4 · More Robert J · Aug 12, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Schedule 13G/A · Vanguard Portfolio Management LLC · Jul 31, 2026
- Form 4 · Coughlin Timothy · Jun 10, 2026
- Form 4 · Napolitano Janet · Jun 2, 2026